Business Context and Reporting Period
Company: MacroGenics, Inc. (MGNX)
Filing Type: Form 8-K (Current Report)
Report Date: May 13, 2026
Reporting Period: Quarter ended March 31, 2026
Context: The Company announced financial and operating results for the quarter. The full details are contained in a press release attached as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a notification of results and does not contain specific numerical data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to Exhibit 99.1 for these figures.
Material Changes
The filing text does not provide a clear value or description of material changes versus the prior comparable period. Specific operational or financial variances are detailed in the attached press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. These disclosures are expected to be found within the attached press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 13, 2026) for specific revenue, net income, and cash flow figures.
- Verify year-over-year and quarter-over-quarter performance metrics in the attached press release.
- Check for any updated forward-looking guidance or clinical trial milestones mentioned in the press release.
- Confirm liquidity position and cash burn rate as detailed in the full financial announcement.